Ozcan, B.; Blachot-Minassian, B.; Paradis, S.; Mazière, L.; Chambion-Diaz, M.; Bouyon, S.; Pépin, J.-L.; Pialoux, V.; Arnaud, C.; Moinard, C.;
et al. L-Citrulline Supplementation Reduces Blood Pressure and Myocardial Infarct Size under Chronic Intermittent Hypoxia, a Major Feature of Sleep Apnea Syndrome. Antioxidants 2022, 11, 2326.
https://doi.org/10.3390/antiox11122326
AMA Style
Ozcan B, Blachot-Minassian B, Paradis S, Mazière L, Chambion-Diaz M, Bouyon S, Pépin J-L, Pialoux V, Arnaud C, Moinard C,
et al. L-Citrulline Supplementation Reduces Blood Pressure and Myocardial Infarct Size under Chronic Intermittent Hypoxia, a Major Feature of Sleep Apnea Syndrome. Antioxidants. 2022; 11(12):2326.
https://doi.org/10.3390/antiox11122326
Chicago/Turabian Style
Ozcan, Bilgehan, Britanny Blachot-Minassian, Stéphanie Paradis, Lucile Mazière, Marie Chambion-Diaz, Sophie Bouyon, Jean-Louis Pépin, Vincent Pialoux, Claire Arnaud, Christophe Moinard,
and et al. 2022. "L-Citrulline Supplementation Reduces Blood Pressure and Myocardial Infarct Size under Chronic Intermittent Hypoxia, a Major Feature of Sleep Apnea Syndrome" Antioxidants 11, no. 12: 2326.
https://doi.org/10.3390/antiox11122326
APA Style
Ozcan, B., Blachot-Minassian, B., Paradis, S., Mazière, L., Chambion-Diaz, M., Bouyon, S., Pépin, J.-L., Pialoux, V., Arnaud, C., Moinard, C., & Belaidi, E.
(2022). L-Citrulline Supplementation Reduces Blood Pressure and Myocardial Infarct Size under Chronic Intermittent Hypoxia, a Major Feature of Sleep Apnea Syndrome. Antioxidants, 11(12), 2326.
https://doi.org/10.3390/antiox11122326